姜天俊, 黄辉煌, 宋兵, 李文刚, 牟劲松, 徐哲, 刘庆艳, 赵鹏, 黄加干, 毕京峰, 王福生. 重症2019冠状病毒病早期临床特征及重症化危险因素分析[J]. 解放军医学院学报, 2020, 41(12): 1171-1175. DOI: 10.3969/j.issn.2095-5227.2020.12.001
引用本文: 姜天俊, 黄辉煌, 宋兵, 李文刚, 牟劲松, 徐哲, 刘庆艳, 赵鹏, 黄加干, 毕京峰, 王福生. 重症2019冠状病毒病早期临床特征及重症化危险因素分析[J]. 解放军医学院学报, 2020, 41(12): 1171-1175. DOI: 10.3969/j.issn.2095-5227.2020.12.001
JIANG Tianjun, HUANG Huihuang, SONG Bing, LI Wen'gang, MOU Jinsong, XU Zhe, LIU Qingyan, ZHAO Peng, HUANG Jiagan, BI Jingfeng, WANG Fusheng. Early clinical characteristics and risk factors of severe COVID-19[J]. ACADEMIC JOURNAL OF CHINESE PLA MEDICAL SCHOOL, 2020, 41(12): 1171-1175. DOI: 10.3969/j.issn.2095-5227.2020.12.001
Citation: JIANG Tianjun, HUANG Huihuang, SONG Bing, LI Wen'gang, MOU Jinsong, XU Zhe, LIU Qingyan, ZHAO Peng, HUANG Jiagan, BI Jingfeng, WANG Fusheng. Early clinical characteristics and risk factors of severe COVID-19[J]. ACADEMIC JOURNAL OF CHINESE PLA MEDICAL SCHOOL, 2020, 41(12): 1171-1175. DOI: 10.3969/j.issn.2095-5227.2020.12.001

重症2019冠状病毒病早期临床特征及重症化危险因素分析

Early clinical characteristics and risk factors of severe COVID-19

  • 摘要:
      目的  总结重型和危重型2019冠状病毒病(COVID-19)患者的早期临床特征,分析重症发生危险因素。
      方法  以2020年1 - 3月在解放军总医院第五医学中心住院的确诊为重型和危重型COVID-19患者为重症组,轻型和普通型患者为轻症组。分析危重症患者的早期临床特征和重症发生的危险因素。
      结果  63例COVID-19患者入组本研究,其中重症组21例,男性11例(52.4%),女性10例(47.6%),平均年龄(61.6±16.4)岁;轻症组42例,男性25例(59.5%),女性17例(40.5%),平均年龄(40.7±15.7)岁。重症组患者畏寒 (23.8% vs 4.7%)、乏力(71.4% vs 21.4%)、咯血(14.3% vs 0)、胸闷或憋气(28.6% vs 2.4%)发生率均明显高于轻症组(P均<0.05)。重症组患者外周血淋巴细胞计数显著低于轻症组(0.92±0.47)×109/L vs (1.64±0.67)×109/L;CD4+和CD8+ T淋巴细胞计数Md(IQR): 167 (107,283)/μL vs 520(238,597)/μL、108(103,210)/μL vs 425(290,533)/μL显著低于轻症组;重症组与轻症组的C反应蛋白(C reactive protein,CRP) 20.84(9.66,37.00) mg/L vs 4.55(1.60,9.30) mg/L、血沉41.0(32.0,59.0) mm/1 h vs 11.5(7.0,25.0) mm/1 h、降钙素原0.09(0.05,0.26) ng/mL vs 0.04(0.03,0.06) ng/mL、IL-619.70(8.91,44.02) pg/mL vs 8.21(5.40,16.70) pg/mL、血清铁蛋白644.9(408.7,1 066.0) U/L vs 281.75(80.98,430.40) U/L、乳酸脱氢酶(309.1 ± 120.2) U/L vs (212.2 ± 81.5) U/L均高于轻症组,且差异均有统计学意义(P均<0.05)。3) logistic回归分析显示,年龄 ≥ 60岁(OR=24.320,95% CI:2.272 ~ 260.293)、CRP ≥ 16 mg/L (OR=24.320,95% CI:2.272 ~ 260.293)、CD4+ T淋巴细胞计数≤300/μL (OR=14.428,95% CI: 2.000 ~ 104.074)、血清铁蛋白 ≥ 500 U/L(OR=15.513,95% CI: 1.735 ~ 138.702)均为COVID-19重症化的独立危险因素。
      结论  COVID-19重型和危重型病例以60岁以上老年人为主,早期主要表现为发热、畏寒、乏力、咳嗽、胸闷或憋气,少数咯血;患者年龄、CRP、CD4+ T淋巴细胞计数和血清铁蛋白有助于早期预警疾病重症化。

     

    Abstract:
      Objective  To investigate the early clinical features of severe cases with coronavirus disease 2019 (COVID-19) and analyze its early risk factors.
      Methods  From January to March in 2020, the severe and critical cases with COVID-19 diagnosed in the Fifth Medical Center of Chinese PLA General Hospital served as observation group, and patients with moderate and mild COVID-19 served as control group. The general data, clinical manifestations and blood testing results were collected and analyzed to identify the early risk factors of severe COVID-19.
      Results  A total of 63 cases with COVID-19 were enrolled in this study. Of the 21 severe or critically severe patients (severe group), there were 11 males (52.4%) and 10 females (47.6%), with an average age of (61.6±16.4) years. Of the 42 mild or moderate patients, there were 25 males (59.5%) and 17 females (40.5%), with an average age of (40.7±15.7) years. The incidences of chills (22.8% vs 4.7%), fatigue (71.4% vs 21.4%), hemoptysis (14.3% vs 0), chest tightness or suffocation (28.6% vs 2.4%) in patients of the severe group were significantly higher than those of the control group (all P < 0.05). Compared with the mild group, a significant decrease was found in the absolute value of peripheral blood lymphocytes (0.92±0.47×109/L vs 1.64±0.67×109/L), CD4+ 167 (MdIQR: 107, 283/μL vs 520238, 597/μL) and CD8+ T lymphocyte count (MdIQR: 108103, 210/μL vs 425290, 533/μL) in patients of the severe group, and an obviously increase in C reactive protein (MdIQR: 20.849.66, 37.00 mg/L vs 4.551.60, 9.30 mg/L), erythrocyte sedimentation rate (MdIQR: 41.0 32.0, 59.0 mm/h vs 11.57.0, 25.0 mm/h), procalcitonin (MdIQR: 0.090.05, 0.26 ng/mL vs 0.04(0.03, 0.06) ng/mL), IL-6 (MdIQR: 19.708.91, 44.02 pg/mL vs 8.215.40, 16.70 pg/mL), serum ferritin (MdIQR: 644.9408.7, 1 066.0 U/L vs 281.7580.98, 430.40 U/L and lactate dehydrogenase (MdIQR: 309.1±120.2 U/L vs 212.2±81.5 U/L), and the differences were statistically significant (all P < 0.05). Logistic regression analysis revealed that age ≥ 60 years (OR=24.320, 95% CI: 2.272 - 260.293), C reactive protein ≥ 16 mg/L (OR=24.320, 95% CI: 2.272 - 260.293), CD4+ T lymphocytes count ≤ 300/μL (OR=14.428, 95% CI: 2.000 - 104.074), and serum ferritin level ≥ 500 U/L (OR=15.513, 95% CI: 1.735 - 138.702) were independent risk factors for the occurrence of severe COVID-19.
      Conclusion  Patients with severe or critically severe COVID-19 are dominated by the elderly over 60 years. The main early manifestations are fever, chills, fatigue, cough, chest tightness or suffocation, and hemoptysis. Age, CRP, CD4 cell count and serum ferritin contribute to early warnings of the disease severity.

     

/

返回文章
返回